| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Development Officer | Interim Chief Operating Office
3 companies
Johnson Wendy S. is a Director at EXAGEN INC. with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $12K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2021 | XGN Exagen Inc. | Director | Buy | 1,000 | $14.02 | $14,020.00 | New | -26.4% | -67.0% | |
| Jul 14, 2021 | OKUR Onkure Therapeutics, Inc. | Chief Development Officer | Sell | 111,736 | $8.50 | $949,756.00 | -100% | -22.3% | -65.2% | |
| Oct 5, 2015 | ARMP Armata Pharmaceuticals, Inc. | Interim Chief Operating Office | Buy | 1,000 | $4.43 | $4,427.00 | New | - | - |